Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ravi Paluri"'
Autor:
Prachi Bajpai, Sumit Agarwal, Farrukh Afaq, Sameer Al Diffalha, Darshan S. Chandrashekar, Hyung-Gyoon Kim, Abigail Shelton, C. Ryan Miller, Santosh K. Singh, Rajesh Singh, Sooryanarayana Varambally, Ganji Purnachandra Nagaraju, Ashish Manne, Ravi Paluri, Moh’d Khushman, Upender Manne
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-18 (2024)
Abstract Background Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in overall survival but is associated with severe toxicities. Thus, to reduce regorafenib-induced
Externí odkaz:
https://doaj.org/article/0aee3c95ec79417fba66f7c7f7661819
Publikováno v:
Oncology Reviews, Vol 13, Iss 1 (2019)
Biomarkers play an essential role in the management of patients with invasive cancers. Pancreatic ductal adenocarcinoma (PDC) associated with poor prognosis due to advanced presentation and limited therapeutic options. This is further complicated by
Externí odkaz:
https://doaj.org/article/da1fe8e1565946deaa25a986ee93e913
Autor:
Elena Garralda Cabanas, Elisa Fontana, Honey Kumar Oberoi, Nataliya V. Uboha, Ecaterina E. Dumbrava, Emiliano Calvo, Giuseppe Curigliano, Diwakar Davar, Bridget K. Keenan, Vincent K. Lam, Sudhir Manda, Amitkuma Mehta, Anna Minchom, Alison Moskowitz, Ravi Paluri, Vincent Ribrag, Donald Richards, Lillian Siu, Paul Swiecicki, Trisha Wise-Draper, Jasmine Zain, Andres Forero-Torres, Ping Xu, Stephen Ansell
Publikováno v:
Cancer Research. 83:CT265-CT265
Background: T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) is an inhibitory immune checkpoint receptor expressed on subsets of T-cells and natural killer (NK) cells. TIGIT inhibits T and NK
Publikováno v:
The oncologist. 27(6)
Background The purpose of this study was to understand how the COVID-19 pandemic has affected health care patterns and outcomes for patients diagnosed with metastatic pancreatic ductal adenocarcinoma (mPDAC) in 2020 compared with those diagnosed with
Autor:
Grant R. Williams, Smita Bhatia, Matthew Robertson, Crystal Young-Smith, Lakshmin Nandagopal, Ravi Paluri, Noha Sharafeldin, Andrew McDonald, Kelly M. Kenzik, Mustafa AL-Obaidi, Donna Murdaugh, Nabiel Mir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1e772eb214a3ca43bf1016f1b90b5a4
https://doi.org/10.26226/morressier.5cdbe0aa618793e647b129fb
https://doi.org/10.26226/morressier.5cdbe0aa618793e647b129fb
Publikováno v:
Hematological oncology. 33(4)
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematological malignancy derived from precursors of plasmacytoid dendritic cells. Very few cases of BPDCN have been described with lack of skin manifestations at the
Autor:
Ravi, Paluri k *, Karim, Samina *, Cloud, Gretchen *, Lamb, Mary *, Langford, Samantha *, Mineishi, Shin, Shelton, Racquel-innis *, Saad, Ayman, Salzman, Donna, Lamb, Lawrence S.
Publikováno v:
In Blood 6 December 2014 124(21):2474-2474